The pediatric-to-adult care handoff is the worst-handled transition in US medicine.
Aging into Medicare is the famous transition. It has statutory enrollment windows, a national-program apparatus, dedicated handoff staff at every major payor, and sixty years of operational practice. In policy terms: all of the things a transition is supposed to have. There is a worse-handled one fifteen years earlier, when an adolescent with a chronic condition turns nineteen and ages out of pediatric care. Almost no one writes about it.
Pediatric-to-adult is, by every operational measure, the worst-handled transition in US medicine. No national framework. No payor-aligned incentive structure. A population of adolescents and young adults with chronic conditions that is small enough to be politically invisible and large enough to absorb a great deal of avoidable cost when the handoff fails. That last property is, of course, exactly the property that gets a transition ignored: too small to mobilize voters, too expensive to ignore once you do the math.
Cohorts who suffer most are well-named in the clinical literature, and the numbers are not in dispute. Sickle cell disease has the bleakest published profile: mortality risk in the 18-30 age band, the years immediately following pediatric handoff, runs higher than the comparable risk during pediatric care, and the cause-of-death pattern is dominated by complications that pediatric protocols had been actively managing. Type 1 diabetes shows a measurable A1C deterioration in the first two years post-transition that the literature attributes more to lost specialist continuity than to the well-known adolescent-rebellion narrative. Congenital heart disease patients lose specialist continuity in roughly half of cases. Cystic fibrosis transitions are better-handled because the disease itself forced an institutional response in the 1990s. That model has not generalized to other chronic conditions, of course, because the institutional response was disease-specific by accident, not by design.
Three structural gaps appear in nearly every transition that fails.
First, documentation. Pediatric records carry developmental notes, parental-history annotations, and a clinical-narrative density that adult-system EHR templates do not accommodate. What the handoff produces, technically, is a transfer summary; what it actually produces is operational lossiness. Pediatric clinical teams carry, in their heads, a model of the patient no chart can hold. That model does not transfer. Whoever receives the patient on the adult side begins their first visit asking questions the chart cannot answer.
Second, the specialist referral network. Pediatric subspecialists and adult subspecialists practice in non-overlapping networks. A pediatric cardiologist who has managed a congenital condition for fifteen years has a working relationship with the patient's family, the pediatric pharmacist, the school-based care coordinator, and a specific surgical team. None of those relationships transfer. The adult cardiologist receiving the patient rebuilds the network from scratch, while the patient is in the worst possible window to absorb the disruption: leaving home for college or work, losing parental coverage, and discovering that a prescription their pediatric clinic has been refilling for ten years now requires prior authorization from a payor that has never seen their record.
Third, the coverage cliff. The age window in which a young adult ages off parental coverage, ages off Medicaid eligibility on a categorical basis, and is expected to either secure employment that includes group coverage or buy individual coverage on an exchange is, naturally, the same age window in which the medical transition happens. Coincidence, in operational terms, is policy. A coverage gap during this window is routine. Clinical consequence of a coverage gap during a transition is that the transition stops being managed at all.
Three programs have closed these gaps inside their own walls. None of the rest of the country has copied them.
Cincinnati Children's runs the most-studied transition program in the US. Its model is a co-managed clinic phase: pediatric specialist and adult specialist see the patient together for two to four visits during the eighteen-to-twenty-one window, then the adult specialist takes over with the pediatric team available for consultative backup for another year. Transition coordinators staff the program, doing exactly the documentation, referral, and coverage-gap work named above. Outcome data shows the post-transition cohort matching pediatric-era trajectory on the chronic-condition markers that usually deteriorate. Deterioration in the standard handoff is, on this evidence, mostly an artifact of the handoff. Not a property of the patient.
Boston Children's runs a "transition to adult" program at similar shape, with two relevant differences. Boston's program is more disease-specific and runs separate transition tracks for sickle cell, congenital heart disease, IBD, and a handful of other conditions; Cincinnati's is more general. Boston also pairs the clinical handoff with an explicit insurance-navigation handoff, walking the patient through coverage options at the moment of transition rather than treating insurance as the patient's own problem to solve afterward — which is, of course, the default everywhere else.
Got Transition, run out of the National Alliance to Advance Adolescent Health, is not a clinic but a framework. It publishes the "Six Core Elements of Health Care Transition," a process map any health system can adopt without rebuilding specialty rosters. Adoption has been slow. Of the three artifacts in this section, the framework is the most copyable. A health system that wanted to do the work without standing up a Cincinnati-scale program could read the Six Core Elements and have a defensible transition workflow inside six months. Most have not.
What is missing is not clinical. Settled clinical evidence has existed for a decade. Protocol: published. Framework: published. Outcomes: published. What does not exist is a payor-aligned incentive to fund the work. A transition coordinator managing a hundred chronic-condition patients across a transition window is a fully-loaded clinical FTE whose work product is "patients who do not generate emergency-department visits in their twenties." Savings are real, literature documents them, and, of course, they accrue to a payor that the patient may not be on by the time the savings materialize. That is, in operational terms, the entire problem. Clinical case: won. Economic case: requires a payor that holds the patient long enough to internalize the savings, and the set of payors who meet that criterion is small. Smaller still: the set who actually fund transition programs as a covered benefit. Until the gap closes, programs that do this work will continue to be philanthropic-funded and grant-funded, patients who get the benefit will continue to be the patients lucky enough to live within range of those programs' geographies, and everyone else will continue to enter the adult care system with documented worse trajectories.
This is a different kind of failure than the failures that get the policy attention. Not a failure of clinical evidence. Not a failure of protocol design. A failure of payor-incentive alignment in a small, politically invisible cohort, and it has the unfortunate property of being expensive and quiet rather than cheap and loud. Failures that get the attention show up in a single news cycle. This one shows up in a five-year mortality differential.
It is also, on the evidence, more solvable than most. Structural fix: known. Protocol: published. Institutional artifacts: existing. Work that remains is operational: moving the funding model into a position that lets the savings accrue to the entity that paid for the program. A policy problem, not a medical one, and the kind of policy problem that would respond to attention if attention arrived.
The cohort is waiting. Clinical case: settled. Protocol: on the shelf. What is missing is a payor incentive structure that holds the patient long enough to pay for itself, and a public-policy conversation that takes the cohort seriously enough to build one.
—TJ